LENZ Therapeutics, Inc. — Investor Relations & Filings
Filings indexed
329
across all filing types
Latest filing
2026-04-28
Annual Report
Country
US
United States of America
Listing
US
LENZ
LENZ Therapeutics, Inc. is a late-stage pharmaceutical company focused on developing and commercializing ophthalmic therapies to improve vision. Its primary product is VIZZ™ (aceclidine ophthalmic solution) 1.44%, an FDA-approved eye drop for the treatment of presbyopia, the age-related loss of near vision. VIZZ is the first aceclidine-based therapy for this condition, which affects an estimated 1.8 billion people globally. The product is designed to restore near vision, providing a pharmaceutical alternative to reading glasses for a broad patient population.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| ARS - LENZ Therapeutics, Inc. (0001815776) (Filer) | 2026-04-28 | English | |
| 4 - LENZ Therapeutics, Inc. (0001815776) (Issuer) | 2026-03-30 | English | |
| 4 - LENZ Therapeutics, Inc. (0001815776) (Issuer) | 2026-03-30 | English | |
| 4 - LENZ Therapeutics, Inc. (0001815776) (Issuer) | 2026-03-30 | English | |
| 8-K - LENZ Therapeutics, Inc. (0001815776) (Filer) | 2026-03-24 | English | |
| SCHEDULE 13G/A Filing | 2026-02-17 | English |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
13 filings
| |||||
| 38172642 | ARS - LENZ Therapeutics, Inc. (0001815776) (Filer) | 2026-04-28 | English | ||
| 33088240 | 4 - LENZ Therapeutics, Inc. (0001815776) (Issuer) | 2026-03-30 | English | ||
| 33088239 | 4 - LENZ Therapeutics, Inc. (0001815776) (Issuer) | 2026-03-30 | English | ||
| 33088238 | 4 - LENZ Therapeutics, Inc. (0001815776) (Issuer) | 2026-03-30 | English | ||
| 33031540 | 8-K - LENZ Therapeutics, Inc. (0001815776) (Filer) | 2026-03-24 | English | ||
| 31841011 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 31841046 | SCHEDULE 13G/A Filing | 2026-02-05 | English | ||
| 13265430 | Major Shareholding Notification 2026 | 2026-01-21 | English | ||
| 13265429 | 8-K | 2026-01-07 | English | ||
| 13265431 | FORM 4 | 2026-01-06 | English | ||
| 13265432 | FORM 4 | 2026-01-06 | English | ||
| 13265433 | FORM 4 | 2026-01-06 | English | ||
| 13265434 | FORM 4 | 2026-01-06 | English | ||
|
2025
2 filings
| |||||
| 13265435 | 8-K | 2025-12-12 | English | ||
| 13265436 | FORM 4 | 2025-11-20 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Coeptis Therapeutics Holdings, Inc.
Biopharmaceutical company developing cell therapy platforms…
|
COEP | US | Manufacturing |
|
Cogent Biosciences, Inc.
A clinical-stage biotech company developing precision thera…
|
COGT | US | Manufacturing |
|
Cohance Lifesciences Limited
Global CDMO and API platform offering end-to-end solutions …
|
COHANCE | IN | Manufacturing |
|
Coherus Oncology, Inc.
Biopharmaceutical company developing and commercializing im…
|
CHRS | US | Manufacturing |
|
Colinz Laboratories ltd.
Manufactures and markets medicinal formulations across dive…
|
531210 | IN | Manufacturing |
|
COLLEGIUM PHARMACEUTICAL, INC
A biopharmaceutical company developing abuse-deterrent pain…
|
COLL | US | Manufacturing |
|
CollPlant Biotechnologies Ltd
Develops plant-derived collagen for 3D bioprinting of tissu…
|
CLGN | US | Manufacturing |
|
COMPASS Pathways plc
Develops psilocybin treatments for difficult-to-treat menta…
|
CMPS | GB | Manufacturing |
|
Compass Therapeutics, Inc.
Clinical-stage biopharma developing antibody-based therapeu…
|
CMPX | US | Manufacturing |
|
Concord Biotech Limited
R&D-driven producer of fermentation-based APIs and formulat…
|
CONCORDBIO | IN | Manufacturing |
LENZ Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32045/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32045 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32045 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32045 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32045}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for LENZ Therapeutics, Inc. (id: 32045)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.